Balofloxacin
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 524369

CAS#: 127294-70-6

Description: Balofloxacin is a fluoroquinolone antibiotic. Balofloxacin has shown potent bactericidal activity & inhibited the supercoiling activity of DNA gyrase of S. aureus, E. coli, & P aeruginosa. It is sold under the brand name Q-Roxin in Korea.

Chemical Structure

img
Balofloxacin
CAS# 127294-70-6
Product data Instruction

Theoretical Analysis

MedKoo Cat#: 524369
Name: Balofloxacin
CAS#: 127294-70-6
Chemical Formula: C20H24FN3O4
Exact Mass: 389.18
Molecular Weight: 389.420
Elemental Analysis: C, 61.68; H, 6.21; F, 4.88; N, 10.79; O, 16.43

Price and Availability

Size Price Availability Quantity
1g USD 250 2 Weeks
2g USD 400 2 Weeks
5g USD 650 2 Weeks
Bulk inquiry

Synonym: Balofloxacin; Balofloxacin [INN]; Q 35; UNII-Q022B63JPM; Q-35; Q35;

IUPAC/Chemical Name: (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)piperidino)-4-oxo-3-quinolinecarboxylic acid

InChi Key: MGQLHRYJBWGORO-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H24FN3O4/c1-22-11-4-3-7-23(9-11)17-15(21)8-13-16(19(17)28-2)24(12-5-6-12)10-14(18(13)25)20(26)27/h8,10-12,22H,3-7,9H2,1-2H3,(H,26,27)

SMILES Code: CNC1CCCN(C1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)O)C4CC4)F

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Product Data
Instruction:
View handling instruction
Biological target: Balofloxacin (Q-35) is a fluoroquinolone antibiotic with broad-spectrum antibacterial activity against gram-negative, gram-positive, and anaerobic bacteria.
In vitro activity: In vitro testing compared the cellular toxicity of and bacterial susceptibility to balofloxacin and levofloxacin in human corneal epithelial cells (HCECs). In vitro toxicity examinations showed that balofloxacin, as well as levofloxacin, had low cytotoxicity in HCECs. Balofloxacin eye drops (0.5%) also showed a similar relative cytotoxicity to levofloxacin eye drops (0.5%). In bacterial susceptibility examinations, both balofloxacin and levofloxacin significantly reduced S. aureus compared with the untreated control (P<0.001 for both balofloxacin and levofloxacin). Reference: J Ocul Pharmacol Ther. 2014 Aug;30(6):482-8. https://www.liebertpub.com/doi/10.1089/jop.2013.0178?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
In vivo activity: For in vivo testing, experimental bacterial keratitis was induced and treated with balofloxacin eye drops (0.5%) and levofloxacin eye drops (0.5%). Balofloxacin was more effective than levofloxacin in the treatment of S. aureus bacterial keratitis (P<0.05). In experimental bacterial keratitis treatment testing, balofloxacin was also more effective than levofloxacin with respect to the parameters of physiological score, histological observation, and bacterial quantitation (P<0.05). Reference: J Ocul Pharmacol Ther. 2014 Aug;30(6):482-8. https://www.liebertpub.com/doi/10.1089/jop.2013.0178?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
Water 2.8 7.29
DMSO 0.8 2.16
DMF 10.0 25.68
DMF:PBS (pH 7.2) (1:1) 0.5 1.28

Preparing Stock Solutions

The following data is based on the product molecular weight 389.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Jiang H, Han S, Guo C, Liu T, Wu X. In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis. J Ocul Pharmacol Ther. 2014 Aug;30(6):482-8. doi: 10.1089/jop.2013.0178. Epub 2014 May 14. PMID: 24828089.
In vitro protocol: 1. Jiang H, Han S, Guo C, Liu T, Wu X. In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis. J Ocul Pharmacol Ther. 2014 Aug;30(6):482-8. doi: 10.1089/jop.2013.0178. Epub 2014 May 14. PMID: 24828089.
In vivo protocol: 1. Jiang H, Han S, Guo C, Liu T, Wu X. In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis. J Ocul Pharmacol Ther. 2014 Aug;30(6):482-8. doi: 10.1089/jop.2013.0178. Epub 2014 May 14. PMID: 24828089.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Chen XH, Zhang BW, Li H, Peng XX. Myo-inositol improves the host's ability to eliminate balofloxacin-resistant Escherichia coli. Sci Rep. 2015 Jun 1;5:10720. doi: 10.1038/srep10720. PubMed PMID: 26030712.

2: Ma X, Yan J, Wang Q, Wu D, Li H. Spectroscopy study and co-administration effect on the interaction of mycophenolic acid and human serum albumin. Int J Biol Macromol. 2015;77:280-6. doi: 10.1016/j.ijbiomac.2015.03.052. Epub 2015 Apr 1. PubMed PMID: 25841376.

3: Jiang H, Han S, Guo C, Liu T, Wu X. In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis. J Ocul Pharmacol Ther. 2014 Aug;30(6):482-8. doi: 10.1089/jop.2013.0178. Epub 2014 May 14. PubMed PMID: 24828089.

4: Li H, Pan JY, Liu XJ, Gao JX, Wu HK, Wang C, Peng XX. Alterations of protein complexes and pathways in genetic information flow and response to stimulus contribute to Escherichia coli resistance to balofloxacin. Mol Biosyst. 2012 Sep;8(9):2303-11. Epub 2012 Jun 22. PubMed PMID: 22729160.

5: Li P, Liu X, Li H, Peng XX. Downregulation of Na(+)-NQR complex is essential for Vibrio alginolyticus in resistance to balofloxacin. J Proteomics. 2012 May 17;75(9):2638-48. doi: 10.1016/j.jprot.2012.03.006. Epub 2012 Mar 17. PubMed PMID: 22465713.

6: Feng LS, Liu ML, Wang B, Chai Y, Hao XQ, Meng S, Guo HY. Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives. Eur J Med Chem. 2010 Aug;45(8):3407-12. doi: 10.1016/j.ejmech.2010.04.027. Epub 2010 May 20. PubMed PMID: 20493593.